Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Vaccine candidate containing tetanus toxoid potentially protective against SARS-CoV-2

Researchers from Cuba, China, and France have demonstrated the potential of coupling a viral antigen with the tetanus toxoid protein as a vaccination approach to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

14 Feb 2021

New tool enables study of SARS-CoV-2 mutant spectrum by ultrasequencing

SARS-CoV-2 genome is three times larger than influenza genome. Both consist of NRA molecules that mutate when replicate.

13 Feb 2021

Study reveals the effects of school closures on SARS-CoV-2 transmission among parents, teachers

Most countries introduced school closures during the spring of 2020 despite substantial uncertainty regarding the effectiveness in containing SARS-CoV-2.

13 Feb 2021

Study finds early risk factors for heightened anxiety in young adults during COVID-19

A new study has identified early risk factors that predicted heightened anxiety in young adults during the coronavirus (COVID-19) pandemic.

12 Feb 2021

How effective has the COVID-19 vaccination program been in Israel?

Using publicly available coronavirus disease 2019 (COVID-19) data from Israel, a study suggests the BioNTech-Pfizer BNT162b2 vaccine is proving highly effective in the real world.

12 Feb 2021

S.D. governor gives state high marks in handling the pandemic. Are they deserved?

Covid-19 has pushed states to adopt unique approaches to protect their residents, but few have garnered as much scrutiny as South Dakota.

12 Feb 2021

Rethinking classical epidemiological modeling in light of COVID-19 pandemic

Researchers recently developed an epidemiological model to explore the impact of individual variation in susceptibility and infectivity on transmission dynamics of an infectious disease across inhomogeneous populations.

12 Feb 2021

Scientists demonstrate how glue points and sequence alignment information can flag residue SARS-CoV-2 variants

Researchers in the U.S. have demonstrated how dominant energetic landscape mappings or glue points, along with sequence alignment information can potentially identify key residue mutations and spike protein deletions tied with emerging variants.

12 Feb 2021

Study offers new protocols for high-quality SARS-CoV-2 genomic sequencing

Researchers at the Southern Illinois University, U.S.A. have presented a comprehensive and well-validated set of working protocols for sequencing high-quality SARS-CoV-2 genomes in high throughput from patient samples.

12 Feb 2021

$1 million funding for Australian-first plan to boost primary care research

An Australian-first plan to boost primary care research and drive improved patient outcomes, has been backed by $1 million in grant funding.

12 Feb 2021

Researchers identify protein sequences involved in SARS-CoV-2 infection

In the early days of the COVID-19 pandemic, it was established that SARS-CoV-2 infects cells by binding to the human protein ACE2, which plays a role in regulating blood pressure.

12 Feb 2021

Reparations before COVID-19 pandemic could have reduced infections, deaths in the U.S.

Civil rights activists have long called for monetary reparations to the Black descendants of Africans enslaved in the United States as a financial, moral, and ethical form of restitution for the injustices of slavery.

12 Feb 2021

People previously infected with COVID-19 respond strongly to one dose of Pfizer vaccine

Although clinical trial data are encouraging, real-world evidence with regard to the COVID-19 vaccine remains scarce. In particular, response to the vaccine among those previously infected with SARS-CoV-2 is still not completely understood.

12 Feb 2021

Portable suitcase lab for rapid detection of SARS-CoV-2

The PCR test is the most accurate tool to identify SARS-CoV-2. However, valid results are often available only after days.

12 Feb 2021

Non-symptomatic cases contribute to at least 50% of SARS-CoV-2 infection

A new study out of the University of Chicago has found that during the initial wave of the COVID-19 outbreak in New York City, only 1 in 5 to 1 in 7 cases of the virus was symptomatic.

11 Feb 2021

Statins shown to reduce COVID-19 severity and lower mortality

Much attention has been focused on ways to reduce the deadly exaggeration of normal inflammatory reactions to this pathogen. A new research paper posted to the medRxiv* preprint server describes the alleviation of hyper-inflammatory phenomena following the administration of statins, drugs more widely known for their use in reducing blood cholesterol levels, to patients with COVID-19.

11 Feb 2021

The impact of SARS-CoV-2 on pregnancy in Nordic countries

Population-based studies are essential to gain knowledge of the spread and management of this disease. However, most studies on pregnancy during COVID-19 have not been broadly applicable to Nordic populations, like most current COVID-19 research in general.

11 Feb 2021

Research reveals vital clues for discovery of COVID-19 drugs

Research from the University of Kent, Goethe-University in Frankfurt am Main, and the Philipps-University in Marburg has provided crucial insights into the biological composition of SARS-CoV-2, the cause of COVID-19, revealing vital clues for the discovery of antiviral drugs.

11 Feb 2021

New SARS-CoV-2 variant found in newborn child with seizures in the United States

Researchers at a hospital in Washington D.C. found a new mutant strain of the virus in a neonatal patient with high viral loads. According to the authors, this strain could be spreading in the United States mid-Atlantic population and needs monitoring.

11 Feb 2021

Self-assessment of face coverings lowers protection against SARS-CoV-2

Researchers in the United States have conducted a study demonstrating that personal assessment of whether respirators and face masks fit properly cannot be relied on in efforts to protect against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

11 Feb 2021

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Vaccine candidate containing tetanus toxoid potentially protective against SARS-CoV-2

New tool enables study of SARS-CoV-2 mutant spectrum by ultrasequencing

Study reveals the effects of school closures on SARS-CoV-2 transmission among parents, teachers

Study finds early risk factors for heightened anxiety in young adults during COVID-19

How effective has the COVID-19 vaccination program been in Israel?

S.D. governor gives state high marks in handling the pandemic. Are they deserved?

Rethinking classical epidemiological modeling in light of COVID-19 pandemic

Scientists demonstrate how glue points and sequence alignment information can flag residue SARS-CoV-2 variants

Study offers new protocols for high-quality SARS-CoV-2 genomic sequencing

$1 million funding for Australian-first plan to boost primary care research

Researchers identify protein sequences involved in SARS-CoV-2 infection

Reparations before COVID-19 pandemic could have reduced infections, deaths in the U.S.

People previously infected with COVID-19 respond strongly to one dose of Pfizer vaccine

Portable suitcase lab for rapid detection of SARS-CoV-2

Non-symptomatic cases contribute to at least 50% of SARS-CoV-2 infection

Statins shown to reduce COVID-19 severity and lower mortality

The impact of SARS-CoV-2 on pregnancy in Nordic countries

Research reveals vital clues for discovery of COVID-19 drugs

New SARS-CoV-2 variant found in newborn child with seizures in the United States

Self-assessment of face coverings lowers protection against SARS-CoV-2

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Newsletters you may be interested in